Tower Research Capital (TRC)’s Cascadia Acquisition Corp. Class A Common Stock CCAI Stock Holding History

Tower Research Capital (TRC)’s Portfolio CCAI Stock Details CCAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-16	Closed	–	–	6561
2022 Q4	$0	Sell	16 -1	-6%	-$10	﹤0.01%	6645
2022 Q3	$0	Buy	17 +6	+55%	+$59	﹤0.01%	6739
2022 Q2	$0	Buy	+11	New	+$108	﹤0.01%	6778

Other funds holding CCAI

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Tower Research Capital (TRC)'s CCAI Position: Q1 2023 in Review

Tower Research Capital (TRC) sold out of Cascadia Acquisition Corp. Class A Common Stock (CCAI) in Q1 2023, closing a stake of 16 shares.

Tower Research Capital (TRC) first reported a position in CCAI in Q2 2022 and held it in 3 quarters. The position peaked at $0 in Q4 2022. 4 funds tracked by Wall St. Rank hold CCAI as of Q1 2023.

Tower Research Capital (TRC) reported no remaining Cascadia Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 16 Cascadia Acquisition Corp. Class A Common Stock shares in Q1 2023.
Tower Research Capital (TRC) first reported a position in Cascadia Acquisition Corp. Class A Common Stock in Q2 2022 and held it in 3 quarters.
Tower Research Capital (TRC)'s Cascadia Acquisition Corp. Class A Common Stock position peaked at $0 in Q4 2022.
4 funds tracked by Wall St. Rank held Cascadia Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.